顺铂—雷替曲塞联合化疗在晚期食管癌和胃癌患者中的ii期研究.docVIP

A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma 表柔比星—顺铂—雷替曲塞联合化疗方案在晚期食管癌和胃癌患者中的II期研究 H. J. Mackay,1 A. Mclnnes,1 J. Paul,1 N. Raby,2 F. J. Lofts,3 A. C. McDonald,1 M. Soukop,4 G. M. Fullarton,5 A. L. Harris,6 J. Garcia-Vargas7 T. R. J. Evans1 Summary 摘要： Background: The aim of this study was to evaluate the efficacy of the combination of epirubicin, cisplatin and ralitrexed (Tomudex), ECT, in patients with advanced oesophageal or gastric adenocarcinoma. Efficacy was assessed primarily as